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Abstract. This work mentions the effect of polyethylene oxide (PEO) content on some 
characteristics and properties of polylactic acid (PLA)/chitosan (CS) films loading nifedipine 
(NIF). The films were prepared by solution method with various PEO content in the range of 0 
to 10 wt% in comparison with total weight of both PLA and CS. The water contact angle, 
droplet size values and Field Emission Scanning Electron Microscopy (FESEM) images  of the 
films were used to investigate their morphology and hydrophobicity. The obtained results show 
that the hydrophobic property of the PLA/CS/NIF films is improved by the presence of PEO. 
Besides, the PLA/CS/NIF films containing PEO have tighter structure and water absorbed ability 
less than those of the PLA/CS/NIF films. The FESEM images of PLA/CS/NIF films with and 
without PEO before and after 28 hours of drug release testing indicated that NIF were released 
from these films. The PLA/CS/NIF films with and without PEO are hydrolyzed with weight loss 
from 22.8 to 90.1 % corresponding to 2 to 28 days of immersing in pH 7.4 solution, respectively. 
Keywords: polyethylene oxide, compatibility, nifedipine, PLA/CS, hydrolysis. 
1. INTRODUCTION 
  Poly lactic acid (PLA) is one of popular biopolymers because it has biodegradation ability 
and can be recycled under the effect of enzymes and microorganisms. As one of environmentally 
friendly polymers, PLA is widely used in many different fields such as textile fibers, packaging 
production and especially in the medical field [1]. Its advantages are high tensile strength and 
hardness large, potential biocompatibility and biodegradation. 
  Chitosan (CS) is a polysaccharide which insoluble in water as well as almost organic 
solvents, however it can be dissolved in some diluted acid solutions. Chitosan and its derivatives 
exhibit many good properties, for example, antifungal and antibacterial ability, high self-
biodegradable [2 - 3]. Therefore, chitosan and its derivatives can be used in many fields such as 
pharmaceutical, biomedical, agricultural, industrial, water treatment and environment protection. 
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  Nifedipine (NIF) is a calcium antagonist drug belonging to the nitro-dihydropyridine group, 
used for anti-hypertensive, anti-angina and treatment of Raynaud disease [4]. NIF has some 
disadvantages such as poor solubility in water, short half-life and rapid release rate. Therefore, in 
order to control the effectiveness and the release rate of NIF in treatment, it is necessary to use 
suitable drug carriers from natural resource. Among them, PLA and CS are suggested as two 
potential polymers thanks to their good characteristics and the ability of controlling drug release 
rate through the formation of the physical interactions between the PLA, CS and drug. However, 
PLA is a hydrophilic polymer while CS is a hydrophobic polymer; and polymer blends of 
PLA/CS have poor compatibility. Hence, using compatibilizers is an effective solution for 
improving compatibility and dispersion ability between PLA and CS. Polyethylene oxide (PEO) 
has chosen as a compatibilizer for PLA and CS due to safety for human body and the C-O 
groups in PEO can interact with the (-C=O), (-OH), (-NH2) groups in the PLA, CS and NIF 
molecules [5, 6]. The obtained PLA/CS films using PEO may have more closely structure and 
the release rate of NIF from the polymer blends of PLA/CS will be controlled easily. 
The solution method is one of the most common methods applied to manufacture the 
polymer system carrying drugs with some advantages: simple manipulation; the reaction occurs 
in solution so the reaction temperature can be controlled. This method has been used by some 
authors in the apothecary of composites loading NIF and some other drugs [7 - 9]. A number of 
works of PLA/CS composites loading some drugs such as paclitaxel, anthraquinone, lamivudine 
has been published [5, 10-13]. In our previous studies, the PLA/CS films loading NIF has been 
prepared successfully by solution method [14]. The SEM images showed that the size of 
dispersed phase (CS and NIF) in PLA matrix is in the range of 100 ÷ 300 nm. The slight shift of 
wavenumber for some groups such as C=O, C-O, OH, NH2 belong to PLA, CS, NIF in the FTIR 
spectrum of PLA/CS/NIF film confirmed that PLA, CS and NIF were interacted with each other. 
The crystallinity relative degree of PLA/CS/NIF film decreased as compared to PLA/CS film. 
Additionally, the characteristics, structure, morphology and degradation ability in the different 
pH solutions of the PLA/CS films using PEO as a compatibilizer were presented in our previous 
works [6,15]. The FTIR and DSC analysis results showed that NIF was carried by PLA/CS/PEO 
nanocomposites and PLA, CS, NIF are better interacted and more compatible when using PEO. 
CS was dispersed more regularly with smaller size in PLA matrix in the presence of PEO. The 
in-vitro NIF release studies were carried out in pH 2, 6.8 and 7.4 solutions corresponding to the 
pH of stomach, colon and duodenum regions in human body for 8 hours, respectively. The NIF 
release content in different pH solutions is in the order: pH 2 > pH 6.8 > pH 7.4, and increases 
when rising NIF loading content. However, the influence of PEO content on the hydrophobicity, 
water absorption ability and morphology of the PLA/CS/NIF/PEO films after drug release 
testing has not been investigated. Therefore, this study presents the effect of various PEO 
content on some above properties and morphology of the PLA/CS/NIF films. 
2. EXPERIMENTAL 
2.1. Materials 
 Poly lactic acid (PLA) in grain form with degree of hydrolyzing of 99 %, density of 1.25 
g/cm3, viscosity of ~2.0 dL/g, averaged molecular weight (Mw) of 260,000, polydispersity index 
(PDI) of ~ 1.5; CS with degree of deacetylation of 77 %, viscosity of 1220 cP, molecular weight 
of 1,61×105. PEO with Mw 100,000, glass temperature of -67 oC; PDI value of 1.02÷1.12; and 
NIF in yellow powder form, purity ≥ 98 % were used. The above chemicals were provided by 
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Sigma-Aldrich Co., USA. Dichloromethane (DCM), acetic acid (CH3COOH) 99.5 %, ethanol 
(C2H5OH) were analytical reagents which have been used without further purification.  
2.2. Fabricating PLA/CS films loading NIF with and without PEO by solution method 
PLA and NIF were dissolved in 12 mL DCM solven (1st cup). The mixture of CS and PEO 
were dissolved in 12.5 mL 1 % acetic acid solution (2nd cup). Two solutions in the cups were 
then stirred separately using magnetic stirrer for 2 hours until a homogeneous solution was 
formed. After that, mixing two solutions was carried out using ultrasonic stirring for 5 minutes 
before magnetic stirring for 7 minutes.  This process was repeated by 3 continuous times. The 
solutions were put into a petri dish and left to evaporate for 32 hours. Then, these films were 
dried in the vacuum for 8 hours at 30-35 °C for obtaining PLA/CS/NIF films. The obtained films 
have thick-ness around 1 ± 0.2 mm. The ratio of components in films and abbreviation of the 
different films are listed in Table 1. 
Table 1. The abbreviation of the different PLA/CS/NIF films: F: film, P: PLA, C: Chitosan, N: Nifedipine, 
P0, 2, 4, 6, 8 and P10 corresponding to PEO content 0, 2, 4, 6, 8 and 10 %, respectively. 
Sample PLA content (%)  CS content (%) NIF content (%) PEO content (%) 
FPCN 72.0 18.0 10 0 
FPCP2N 70.4 17.6 10 2 
FPCP4N 68.8 17.2 10 4 
FPCP6N 67.2 16.8 10 6 
FPCP8N 65.6 16.4 10 8 
FPCP10N 64.0 16.0 10 10 
2.3. Characterization of the PLA/CS/NIF films with and without PEO  
2.3.1. Water contact angle (WCA) 
 The water contact angle of the PLA/CS/NIF films with and without PEO was determined 
by static sessile drop method on the SEO Phoenix-150 meter at the Institute of Energy Science, 
Vietnam Academy of Science and Technology (VAST). Distilled water was placed randomly on 
chosen positions at the surface of the films. The WCA was calculated by average value of 5 
points per specimen and repeated 3 times. 
2.3.2. Field emission scanning electron microscopy (FESEM) 
  Morphology of PLA/CS/NIF films with and without PEO before and after drug release 
studies was observed and imaged on the scanning electron microscopy radiated field device 
(FESEM S- 4800, Hitachi, Japan) at the National Institute of Hygiene and Epidemiology and 
Institute of Materials Science, VAST. 
2.3.3. Water absorption determination 
Water absorption of PLA/CS/NIF films with and without PEO was determined as follows: 
all film specimens were weighed with same weight and immersed in distilled water. After each 
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interval (2 , 4 , 6  and 8 hours), one of 4 film specimens was taken and dried to remove water 
completely from the film. And then, the weight number was weighed and noted exactly. All 
steps were performed 3 times per specimen and taken the average value. Water absorption was 
calculated  by equation below: 
                                       α = (mt - mo)/mo × 100%                                                                      (1) 
where mo and mt are the weight of film before and after immersion (g), respectively. 
2.3.4. Determination of weight loss of PLA/CS/NIF films with and without PEO in pH 7.4 
solution 
Determination of weight loss of the films immersed in pH 7.4 solution was calculated based 
on the change of sample weight after hydrolysis according to following equation:  
                                 m = mr/mi × 100%                                                                              (2)       
where m is the weight loss of samples (%), mi is the initial weight of samples (g) and mr is the 
weight of samples after hydrolysis (g). 
3. RESULTS AND DISCUSSION 
3.1. The hydrophobic/hydrophilic properties of PLA/CS/NIF films with and without PEO 
  Figure 1 presents the value of water contact angle (WCA) of PLA/CS/NIF films with and 
without PEO. It is clear that WCA values of all investigated films are higher than 90o 
corresponding to hydrophobic materials [16]. Moreover, the WCA value of PLA/CS/NIF/PEO 
films is higher than that of the PLA/CS/NIF film. This is explained by the role of PEO as a 
compatibilizer for PLA, CS, and NIF due to hydrogen bonding and dipole - dipole interactions 
between of C=O, C-O, OH, NH groups in PLA, CS, and NH, C-O, C=O, N=O groups in NIF. 
Therefore, it limits water absorption into the surface of these films resulting in the increase of 
their hydrophobicity [16]. The films containing 6 and 8 % PEO have the largest WCA value 
corresponding to the most closely structure which are expressed by morphology of the 
PLA/CS/NIF films with and without PEO (see Section 3.2). 
 
Figure 1. Water contact angle (WCA) of PLA/CS/NIF films with and without PEO. 
3.2. Morphology of the PLA/CS/NIF films with and without PEO 
Figure 2 shows FESEM images of PLA/CS/NIF films with and without PEO. It is 
obviously that the structures of all films are heterogeneous with two phases: PLA matrix phase 
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and the dispersed phase containing CS and NIF. The presence of PEO may help CS and NIF 
better disperse and stick with each other and form smaller nanoparticles due to physical 
interactions as aforementioned. The change in the content of PEO also influences on dispersion 
of CS and NIF in PLA matrix. In FPCN films, CS is dispersed in the PLA with the size about 
10÷20 µm and agglomerated into cluster particles while NIF is dispersed in PLA with smaller 
particle size, about 1µm. At 2 wt% PEO (FPCP2N film), CS particle is dispersed in the range of 
5÷20 µm in PLA matrix and the particle size of NIF is reduced to 200÷500 nm. At 4 wt% PEO 
(FPCP4N film), CS and NIF are dispersed in the PLA phase with the size of 1÷5 µm and 
200÷500 nm, respectively. In particular, CS and NIF are found with the smallest size, only about 
1÷5 µm and 50÷100 nm in FPCP6N film (using 6 wt% PEO). However, in FPCP8N and 
FPCP10N films (using 8 and 10 wt% PEO), CS is dispersed irregularly and agglomerated to 
larger particle clusters, about 10 µm or larger size. This indicates that the PLA/CS/NIF film 
using 6 wt% PEO has more evenly structure and size of CS and NIF dispersed in PLA smaller 
than the films containing other content of PEO. This may be due to small content of PEO is not 
enough to improve the interoperability between PLA, CS and NIF. Nevertheless, with the larger 
PEO content, residual content of PEO after creating bonding and interaction with PLA, CS, NIF 
can cause the phase separation in the structure of films leading to decrease compatibility of PLA, 
CS, PEO and NIF. The dispersion of NIF in PLA/CS/6 wt% PEO film can be observed in 











Figure 2. FESEM images of the PLA/CS/NIF films with various content of PEO at magnification of 1000 







Figure 3. FESEM image of the PLA/CS/NIF/6 wt%  PEO films at magnification of 5000 times.  
FESEM images of PLA/CS/NIF films with and without PEO after 24-hour drug release 
testing in pH 7.4 solution are demonstrated in Figure 4. As results mentioned in our previous 
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paper [6], the release of NIF from PLA/CS/NIF films is according to 2 steps: the first one is fast 
and the second one is slowly. From Figure 4, it is clear that PLA is hydrolyzed and left porous 
structure. In the FESEM image at 20000-time magnifications (Figure 4f), the holes with 50÷100 
nm size are appeared on the surface of CS particles. These holes are created by the drug release 
from the CS porous structure. It can be confirmed that NIF is absorbed and situated in the pores 
of the porous structure of CS and released from PLA/CS/NIF/PEO films. 
   
   
Figure 4. FESEM images of PLA/CS/NIF composite films at difference PEO content (a) 0 wt%  PEO,   
(b) 4 wt%   PEO, (c) 6 wt%   PEO, (d) 8 wt%   PEO, (e) 10 wt%   PEO after 24-hour drug release testing 
in pH 7.4 solution (at 1000-time magnifications). (f) FESEM images of PLA/CS/NIF composite films 
with 6 wt%  PEO content at 20000-time magnifications. 
3.3. Water absorption of PLA/CS/NIF films with and without PEO 
 
Figure 5. Water absorption of PLA/CS/NIF composite films with and without PEO. 
(a) (b) (c) 
(d) (e) (f) 
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Water absorption is an important factor affected on the drug release from the polymer 
materials because drug is released and controlled through the swollen and hydrolyzed process of 
polymers. It corresponds to the water weight remained in the structure of films. For 
PLA/CS/NIF films, PLA has swelling and hydrolysis ability in water and swelling process is 
occurred before hydrolysis process. Water absorption of PLA/CS/NIF films with and without 
PEO is illustrated in Figure 5. It is increased significantly for the first 2 hours, reached 142 % 
and then increased slowly. In contrast, the water absorption of the PLA/CS/NIF films is lower 
than that the sample without PEO and there is not much difference of the films with various 
content of PEO during investigation time. 
In the presence of PEO, the interaction and dispersion between PLA, CS and NIF are 
improved clearly through hydrogen bonding and dipole-dipole interactions as mentioned in [16]. 
Among tested films, the FPCP6N and FPCP8N samples have the lowest water absorption due to 
their structure of PLA/CS/NIF films became more closely (see above 3.1. and 3.2). Therefore, 
the penetration of water molecules into the structure of films is limited and water absorption of 
the films using PEO is declined. 
The water absorption value of PLA/CS/NIF films in this work is similar to that of 
chitosan/polylactide/Cloisite 30B composite materials carrying paclitaxel drug during the survey 
published by R. Nanda et al. [8].  
3.4. Weight loss of PLA/CS/NIF films with and without PEO in pH 7.4 solution 
Table 2 diplays the weight loss of PLA/CS/NIF films with and without PEO after 2, 7,               
14 and 28 days of immersing in pH 7.4 solution. All investigated films have weight loss from 
22.8 % to 90.1 % as increasing with immersing time. This indicates that PLA and NIF 
containing ester groups are hydrolyzed in pH 7.4 solution. The weight loss of PLA/CS/NIF/PEO 
films (FPCPN) is lower than that of PLA/CS/NIF film without PEO (FPCN) at the same time of 
testing. It expresses that PLA/CS/NIF/PEO films have tighter structure causing the slower 
hydrolysis. The weight loss of FPCP6N and FPCP8N films is smaller than that of others. So, the 
suitable content of PEO for preparation of PLA/CS/NIF/PEO films is 6 and 8 wt %.  
Table 2. Weight loss of PLA/CS/NIF films with and without PEO immersed in pH 7.4 solution.  
 
Samples 
Weight loss (%)   
2 days 7 days 14 days 28 days 
FPCN 27.3 66.1 80.0 90.1 
FPCP2N 26.2 60.6 77.3 85.5 
FPCP4N 25.7 62.7 73.2 83.8 
FPCP6N 23.4 55.9 68.7 76.3 
FPCP8N 22.8 49.6 64.2 74.6 
FPCP10N 27.5 62.2 78.1 83.9 
4. CONCLUSIONS 
PEO has an important role in significant improvement of the interaction between PLA, CS 
and NIF. The PEO content is affected on hydrophobicity and water absorption of the 
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PLA/CS/NIF films. Using PEO in PLA/CS/NIF films, CS and NIF are dispersed more regularly 
with the smaller size in comparison to PLA/CS/NIF film. Especially, at 6 % of PEO content, CS 
and NIF are dispersed with smallest size, about 1÷5 µm and 50÷100 nm, respectively. NIF is 
released from the PLA/CS/NIF/PEO films and left holes in the structure of these films immersed 
in pH 7.4 solution. It confirms that the PLA/CS/NIF films with and without PEO are hydrolyzed 
in pH 7.4 solution. The suitable content of PEO for preparation of PLA/CS/NIF/PEO films is 6 
wt % and 8 wt %.  
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